Interferon-signaling pathway: associations with colon and rectal cancer risk and subsequent survival.
about
HnRNP A1/A2 and SF2/ASF regulate alternative splicing of interferon regulatory factor-3 and affect immunomodulatory functions in human non-small cell lung cancer cellsThe associations between immunity-related genes and breast cancer prognosis in Korean women.Interferons and their stimulated genes in the tumor microenvironmentPolymorphisms in the TNFA and IL6 genes represent risk factors for autoimmune thyroid diseaseSingle nucleotide polymorphisms within interferon signaling pathway genes are associated with colorectal cancer susceptibility and survival.A pathway approach to evaluating the association between the CHIEF pathway and risk of colorectal cancer.A Survival Association Study of 102 Polymorphisms Previously Associated with Survival Outcomes in Colorectal CancerInterferon Regulatory Factor 6 Has a Protective Role in the Host Response to Endotoxic ShockInterleukin genes and associations with colon and rectal cancer risk and overall survival.Propyl gallate inhibits TPA-induced inflammation via the nuclear factor-κB pathway in human THP-1 monocytes.Radiation and SN38 treatments modulate the expression of microRNAs, cytokines and chemokines in colon cancer cells in a p53-directed mannerGenes, environment and gene expression in colon tissue: a pathway approach to determining functionalityGenetic variation in the lipoxygenase pathway and risk of colorectal neoplasia.Common Genetic Polymorphisms within NFκB-Related Genes and the Risk of Developing Invasive AspergillosisLack of interferon-γ receptor results in a microenvironment favorable for intestinal tumorigenesis.Escape from IFN-γ-dependent immunosurveillance in tumorigenesis.ISG15 in the tumorigenesis and treatment of cancer: An emerging role in malignancies of the digestive system.Colorectal cancer cells suppress CD4+ T cells immunity through canonical Wnt signaling.Genetic variants in the TGFβ-signaling pathway influence expression of miRNAs in colon and rectal normal mucosa and tumor tissue.Differential gene expression of chemokines in KRAS and BRAF mutated colorectal cell lines: role of cytokines.The Protective Role of Type I Interferons in the Gastrointestinal Tract.Multiplexed cytokine profiling of serum for detection of colorectal cancer.Quantitative proteomic profiling of paired cancerous and normal colon epithelial cells isolated freshly from colorectal cancer patients.Role of Type I and II Interferons in Colorectal Cancer and Melanoma.Interaction of TLR-IFN and HLA polymorphisms on susceptibility of chronic HBV infection in Southwest Han Chinese.Lack of association between interferon gamma +874 T/A polymorphism and cancer risk: an updated meta-analysis.Investigation of single and synergic effects of NLRC5 and PD-L1 variants on the risk of colorectal cancer.Colorectal cancer prevention: Immune modulation taking the stage.The variant interleukin 1f7 rs3811047 G>A was associated with a decreased risk of gastric cardiac adenocarcinoma in a Chinese Han population.Inhibition of Fas associated phosphatase 1 (Fap1) facilitates apoptosis of colon cancer stem cells and enhances the effects of oxaliplatin.
P2860
Q21559659-E69F0A85-D542-4CD8-AD8D-77B11244F89AQ33975510-AB10707E-06E2-445F-826E-2996BFD41834Q33988567-E62CE806-5ACF-47A1-8DF4-90E32FEB5C6BQ34051020-930907C2-6525-499D-8404-1C1D78BAF9AAQ34414731-D750DD53-84B1-4FDF-9BCD-33A8AAED0C37Q34917952-73BEBCD9-1394-4E8C-AE50-57E8131B8F84Q35647279-52EEFBEE-24AC-4528-85ED-12898A98EF1DQ35976278-8A51BABC-79F8-4EDB-8908-C93220ADA40FQ36315711-03737DE4-7DA7-4812-AD88-555C402F4E39Q36604033-9EB9E110-9F1A-4F14-B787-006BAEC0D3ECQ36689088-3D55C508-FD34-4664-B5DC-3893FF985181Q36874951-8AE760F7-88AE-4E29-9A47-D6233C0BCE6AQ36974684-469E2877-C5F5-4493-8E60-4893EFE58E49Q37169890-9159BD4E-9FBD-4A34-B67F-28CF9703F5E3Q37520458-227684D9-7419-44C6-BDA7-75763492B164Q37618482-F12BA766-4552-484E-9E37-B359C79BE9D6Q37687572-2762B358-BA07-4621-ABCB-F44B118AE70EQ37716516-C6EFFB32-99C4-4AA8-AA4A-50A89BCD6386Q37725516-26B6FE83-50BC-4DED-82EE-079C71A2A82FQ38366270-23275C5A-A7E5-4C70-95A0-FAA89B1284A6Q39253724-01310164-41EE-495D-AEC2-6DFC413D5ADFQ39388171-8FC4B053-C320-44DB-B0AA-660922F75075Q40413351-2587E376-19F0-4568-8A89-819600F71FE3Q41123286-9E5A0691-E118-48F2-999A-251C0F6D1663Q41621344-5A98AC7C-6583-4DEB-BA2B-A0624A87A9E2Q46911442-476926BE-1A9F-4F37-9699-5FAC4EB0C9B9Q48097366-1A176150-DE2B-4C88-B40F-17750A1134B1Q49391998-8B8834EE-E390-4E83-995A-316E8CE6D72BQ54414260-CE5C3A0C-3405-4E99-A522-24F4D477D95BQ55285088-720C005B-6120-45A5-BD9F-5CAA7C02DDD9
P2860
Interferon-signaling pathway: associations with colon and rectal cancer risk and subsequent survival.
description
2011 nî lūn-bûn
@nan
2011 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
name
Interferon-signaling pathway: ...... risk and subsequent survival.
@ast
Interferon-signaling pathway: ...... risk and subsequent survival.
@en
type
label
Interferon-signaling pathway: ...... risk and subsequent survival.
@ast
Interferon-signaling pathway: ...... risk and subsequent survival.
@en
prefLabel
Interferon-signaling pathway: ...... risk and subsequent survival.
@ast
Interferon-signaling pathway: ...... risk and subsequent survival.
@en
P2093
P2860
P356
P1433
P1476
Interferon-signaling pathway: ...... risk and subsequent survival.
@en
P2093
Abbie Lundgreen
Kristina L Bondurant
Roger K Wolff
P2860
P304
P356
10.1093/CARCIN/BGR189
P407
P577
2011-08-22T00:00:00Z